Cargando…

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine

Detalles Bibliográficos
Autores principales:	Greco, Rosaria, Francavilla, Miriam, Demartini, Chiara, Zanaboni, Anna Maria, Sodergren, Mikael H., Facchetti, Sara, Pacchetti, Barbara, Palmisani, Michela, Franco, Valentina, Tassorelli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240682/ https://www.ncbi.nlm.nih.gov/pubmed/37277720 http://dx.doi.org/10.1186/s10194-023-01605-1

Ejemplares similares

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2021)

Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
por: Demartini, Chiara, et al.
Publicado: (2023)

Endocannabinoid System and Migraine Pain: An Update
por: Greco, Rosaria, et al.
Publicado: (2018)

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
por: Demartini, Chiara, et al.
Publicado: (2022)

Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model
por: Demartini, Chiara, et al.
Publicado: (2017)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
por: Greco, Rosaria, et al.
Publicado: (2020)

Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing
por: Greco, Rosaria, et al.
Publicado: (2018)

Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis
por: Corrado, Michele, et al.
Publicado: (2022)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks
por: De Icco, Roberto, et al.
Publicado: (2021)

Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model
por: Demartini, Chiara, et al.
Publicado: (2018)

P007. Inhibition of monoacylglycerol lipase activity modulates the activation of brain structures relevant for migraine pathogenesis
por: Greco, Rosaria, et al.
Publicado: (2015)

Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
por: Greco, Rosaria, et al.
Publicado: (2021)

On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva
por: Franco, Valentina, et al.
Publicado: (2022)

Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
por: Mottarlini, Francesca, et al.
Publicado: (2022)

Effects of anandamide in migraine: data from an animal model
por: Greco, Rosaria, et al.
Publicado: (2011)

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
por: Greco, Rosaria, et al.
Publicado: (2014)

The Endocannabinoid Analgesic Entourage Effect: Investigations in Cultured DRG Neurons
por: Anand, Uma, et al.
Publicado: (2022)

Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications
por: Rosignoli, Chiara, et al.
Publicado: (2022)

Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons
por: Anand, Uma, et al.
Publicado: (2021)

Profiling the Biochemical Signature of GBA‐Related Parkinson's Disease in Peripheral Blood Mononuclear Cells
por: Avenali, Micol, et al.
Publicado: (2021)

Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
por: Bottiroli, Sara, et al.
Publicado: (2021)

EHMTI-0141. URB937 as a potential therapeutic option for migraine: evaluation in animal model of migraine
por: Greco, R, et al.
Publicado: (2014)

Real World Evidence in Medical Cannabis Research
por: Banerjee, Rishi, et al.
Publicado: (2021)

Effects of URB937 on an animal model of migraine pain
por: Greco, R, et al.
Publicado: (2013)

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial
por: Martelletti, Paolo, et al.
Publicado: (2018)

CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons
por: Anand, Uma, et al.
Publicado: (2020)

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
por: Mabou Tagne, Alex, et al.
Publicado: (2019)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial
por: Grazzi, Licia, et al.
Publicado: (2019)

Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
por: Ament, Michael, et al.
Publicado: (2021)

Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis
por: Genovese, Tiziana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6ksacgq1m2q0rhhln5v9oqa5s